04/17/2024
6:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:08 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:19 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:20 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/05/2024
4:58 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:50 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:51 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:52 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:00 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
6:09 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
02/29/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:05 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:44 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
02/20/2024
6:52 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
5:03 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:16 AM | Iovance Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
4:40 PM | Iovance Biotherapeutics (Subject)
MHR FUND MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/25/2024
9:49 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:09 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:09 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:24 PM | Iovance Biotherapeutics (Subject)
Quogue Capital LLC (Filed by)
| Form SC 13D/A | |
10/18/2023
7:03 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
7:04 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
7:05 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:30 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:12 PM | Iovance Biotherapeutics (Issuer)
Rothbaum Wayne P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
7:17 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023
5:21 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:22 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:22 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
3:31 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
07/11/2023
4:08 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
07/11/2023
3:55 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:27 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
07/10/2023
3:40 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
7:53 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:51 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:39 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
06/16/2023
3:11 PM | Iovance Biotherapeutics (Filer)
| Form S-3ASR | |
06/08/2023
5:20 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:20 PM | Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:21 PM | Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:21 PM | Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:21 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:22 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
4:17 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
3:30 PM | Iovance Biotherapeutics (Filer)
| Form 8-K/A | |
05/26/2023
7:38 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
3:30 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:30 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/27/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/26/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/26/2023
4:16 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
